2 results
Approved WMOCompleted
Primary objective: To demonstrate that QVA149 (110/50 *g o.d.) is superior to NVA237 (50 *g o.d.) with regard to the rate of moderate to severe COPD exacerbations during 64 weeks of treatmentSecondary objectives: To demonstrate that QVA149 (110/50 *…
Approved WMOWill not start
Determine the safety and preliminary efficacy of the new ACE Stapler in the specific tissue apposition application of repairing dilated post-surgical gastric anatomy over a 12 month follow-up period.